TD Asset Management’s Quest Diagnostics DGX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$13.4M Buy
63,266
+5,661
+10% +$1.11M 0.01% 594
2026
Q1
$11.3M Buy
57,605
+2,617
+5% +$508K 0.01% 618
2025
Q4
$9.54M Sell
54,988
-65,893
-55% -$12M 0.01% 670
2025
Q3
$23M Sell
120,881
-133
-0.1% -$23.6K 0.02% 477
2025
Q2
$21.7M Buy
121,014
+18,484
+18% +$3.21M 0.02% 479
2025
Q1
$17.3M Buy
102,530
+6,825
+7% +$1.12M 0.02% 526
2024
Q4
$14.4M Buy
95,705
+9,597
+11% +$1.49M 0.01% 574
2024
Q3
$13.3M Buy
86,108
+43,676
+103% +$6.52M 0.01% 593
2024
Q2
$5.81M Buy
42,432
+1,399
+3% +$192K 0.01% 730
2024
Q1
$5.46M Buy
41,033
+934
+2% +$121K 0.01% 755
2023
Q4
$5.53M Buy
40,099
+2,431
+6% +$320K 0.01% 740
2023
Q3
$4.59M Sell
37,668
-4,541
-11% -$605K 0.01% 753
2023
Q2
$5.93M Sell
42,209
-4,927
-10% -$679K 0.01% 704
2023
Q1
$6.67M Buy
47,136
+3,697
+9% +$529K 0.01% 682
2022
Q4
$6.8M Buy
43,439
+4,312
+11% +$620K 0.01% 675
2022
Q3
$4.88M Sell
39,127
-29,720
-43% -$3.91M 0.01% 764
2022
Q2
$9.15M Sell
68,847
-22,321
-24% -$3.04M 0.01% 632
2022
Q1
$12.5M Buy
91,168
+13,354
+17% +$1.86M 0.01% 598
2021
Q4
$13.5M Buy
77,814
+8,611
+12% +$1.31M 0.01% 612
2021
Q3
$10.1M Buy
69,203
+2,145
+3% +$314K 0.01% 650
2021
Q2
$9.51M Sell
67,058
-16,584
-20% -$2.17M 0.01% 659
2021
Q1
$10.7M Buy
83,642
+31,538
+61% +$3.89M 0.01% 619
2020
Q4
$6.21M Buy
52,104
+6,224
+14% +$759K 0.01% 734
2020
Q3
$5.25M Buy
45,880
+13,322
+41% +$1.57M 0.01% 697
2020
Q2
$3.71M Sell
32,558
-2,124
-6% -$225K 0.01% 725
2020
Q1
$2.79M Sell
34,682
-5,600
-14% -$580K ﹤0.01% 753
2019
Q4
$4.3M Sell
40,282
-1,743
-4% -$182K 0.01% 746
2019
Q3
$4.5M Buy
42,025
+1,390
+3% +$143K 0.01% 708
2019
Q2
$4.14M Sell
40,635
-16,192
-28% -$1.56M 0.01% 723
2019
Q1
$5.11M Sell
56,827
-9,370
-14% -$812K 0.01% 690
2018
Q4
$5.51M Buy
66,197
+23,292
+54% +$2.18M 0.01% 631
2018
Q3
$4.63M Buy
42,905
+397
+0.9% +$43.5K 0.01% 751
2018
Q2
$4.67M Buy
42,508
+3,487
+9% +$363K 0.01% 725
2018
Q1
$3.91M Sell
39,021
-4,277
-10% -$438K 0.01% 732
2017
Q4
$4.26M Sell
43,298
-1,826
-4% -$173K 0.01% 714
2017
Q3
$4.22M Sell
45,124
-20,346
-31% -$2.16M 0.01% 687
2017
Q2
$7.28M Sell
65,470
-13,153
-17% -$1.39M 0.01% 591
2017
Q1
$7.72M Sell
78,623
-5,711
-7% -$544K 0.01% 594
2016
Q4
$7.75M Buy
84,334
+5,951
+8% +$513K 0.01% 576
2016
Q3
$6.63M Sell
78,383
-14,003
-15% -$1.18M 0.01% 632
2016
Q2
$7.52M Buy
92,386
+442
+0.5% +$33.7K 0.01% 582
2016
Q1
$6.57M Sell
91,944
-9,611
-9% -$645K 0.01% 596
2015
Q4
$7.22M Sell
101,555
-12,267
-11% -$825K 0.01% 551
2015
Q3
$7M Sell
113,822
-7,700
-6% -$538K 0.01% 543
2015
Q2
$8.81M Sell
121,522
-16,691
-12% -$1.23M 0.02% 539
2015
Q1
$10.6M Buy
138,213
+11,453
+9% +$820K 0.02% 476
2014
Q4
$8.5M Buy
126,760
+30,455
+32% +$1.92M 0.01% 530
2014
Q3
$5.84M Sell
96,305
-58,577
-38% -$3.61M 0.01% 608
2014
Q2
$9.09M Buy
154,882
+13,410
+9% +$785K 0.02% 492
2014
Q1
$8.19M Buy
141,472
+17,590
+14% +$943K 0.01% 513
2013
Q4
$6.63M Buy
123,882
+4,920
+4% +$292K 0.01% 551
2013
Q3
$7.35M Buy
118,962
+20,028
+20% +$1.2M 0.01% 510
2013
Q2
$6M Buy
+98,934
New +$5.89M 0.01% 530

Other funds holding DGX

TD Asset Management's DGX Position: Q2 2026 in Review

TD Asset Management increased its Quest Diagnostics (DGX) stake by 9.8% in Q2 2026, buying an estimated $1.11M and bringing the position to 63,266 shares worth $13.4M. The position accounts for 0.01% of the portfolio, ranked #594.

TD Asset Management first reported a position in DGX in Q2 2013 and has held it in 53 quarters since. The position peaked at $23M in Q3 2025. 919 funds tracked by Wall St. Rank hold DGX as of Q2 2026.

  • TD Asset Management held 63,266 shares of Quest Diagnostics worth $13.4M as of Q2 2026.
  • TD Asset Management bought 5,661 Quest Diagnostics shares in Q2 2026, an estimated $1.11M.
  • Quest Diagnostics made up 0.01% of TD Asset Management's portfolio in Q2 2026, its #594 holding.
  • TD Asset Management first reported a position in Quest Diagnostics in Q2 2013 and has held it in 53 quarters since.
  • TD Asset Management's Quest Diagnostics position peaked at $23M in Q3 2025.
  • 919 funds tracked by Wall St. Rank held Quest Diagnostics as of Q2 2026.

Based on TD Asset Management's 13F filing for Q2 2026, filed 4 Aug 2026.